Ronan Roussel Selected Research

Therapeutics

4/2020	Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues.
1/2020	Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
1/2019	Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I Study.
12/2016	Longitudinal association of antidepressant medication use with metabolic syndrome: Results of a 9-year follow-up of the D.E.S.I.R. cohort study.
10/2016	Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study.
9/2016	Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study.
1/2016	Evaluation of the long-term cost-effectiveness of liraglutide therapy for patients with type 2 diabetes in France.
10/2015	Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis.
1/2014	Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor.
1/2014	Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronan Roussel Research Topics

Disease

73	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2003
18	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2011
17	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021 - 05/2004
15	Insulin Resistance 11/2021 - 11/2004
12	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 09/2012
12	Hypertension (High Blood Pressure) 01/2018 - 11/2004
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2018 - 06/2010
8	Obesity 01/2021 - 08/2003
8	Chronic Renal Insufficiency 01/2019 - 05/2014
7	COVID-19 01/2022 - 01/2020
7	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 04/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2015
6	Proteinuria 10/2019 - 09/2008
6	Myocardial Infarction 01/2018 - 07/2012
5	Kidney Diseases (Kidney Disease) 01/2018 - 01/2014
5	Ischemia 12/2016 - 01/2011
4	Diabetes Complications 01/2021 - 11/2004
4	Albuminuria 06/2017 - 11/2013
4	Stroke (Strokes) 12/2015 - 07/2012
3	Diabetic Foot 01/2021 - 01/2016
3	Weight Gain 01/2021 - 01/2014
3	Atherosclerosis 01/2020 - 04/2016
3	Overweight 01/2020 - 08/2003
3	Glucose Intolerance 01/2020 - 05/2015
3	Heart Failure 12/2018 - 11/2010
3	Fatty Liver 11/2018 - 05/2015
3	Hyperglycemia 01/2017 - 04/2011
3	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2015 - 11/2004
2	Morbid Obesity 01/2022 - 04/2015
2	Weight Loss (Weight Reduction) 01/2021 - 01/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 07/2013
2	Foot Ulcer 12/2019 - 01/2016
2	Diabetes Mellitus 02/2019 - 12/2014
2	Coronary Disease (Coronary Heart Disease) 12/2018 - 01/2009
2	Fibrosis (Cirrhosis) 07/2017 - 09/2012
2	Wounds and Injuries (Trauma) 01/2016 - 01/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2014 - 05/2012

Drug/Important Bio-Agent (IBA)

27	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2004
22	Insulin (Novolin)FDA Link 01/2021 - 09/2008
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
10	Insulin Glargine (Lantus)FDA Link 08/2020 - 01/2018
10	Vasopressins (Vasopressin)IBA 02/2019 - 11/2013
9	CreatinineIBA 10/2019 - 11/2010
6	KininsIBA 01/2017 - 07/2013
5	LipidsIBA 01/2021 - 11/2004
5	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 11/2010
5	AlbuminsIBA 01/2018 - 11/2004
4	AdrenomedullinIBA 01/2022 - 09/2015
4	AdiponectinIBA 11/2021 - 07/2010
4	CholesterolIBA 01/2021 - 05/2015
4	omega-Chloroacetophenone (Mace)IBA 01/2020 - 07/2016
4	Ramipril (Altace)FDA LinkGeneric 07/2016 - 09/2008
4	Advanced Oxidation Protein Products (AOPP)IBA 02/2016 - 01/2014
3	HDL CholesterolIBA 01/2021 - 01/2009
3	SodiumIBA 01/2021 - 05/2011
3	DiureticsIBA 01/2021 - 06/2011
3	InsulinsIBA 08/2020 - 10/2018
3	Insulin Detemir (Levemir)FDA Link 08/2020 - 01/2018
3	insulin degludecIBA 04/2019 - 01/2018
3	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2018 - 07/2009
3	Type I Tumor Necrosis Factor ReceptorsIBA 10/2018 - 05/2014
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 05/2015
3	Atrial Natriuretic Factor (ANF)IBA 01/2016 - 05/2004
3	Hypoglycemic Agents (Hypoglycemics)IBA 11/2015 - 08/2013
3	Superoxide DismutaseIBA 01/2015 - 12/2011
3	Tissue Kallikreins (Tissue Kallikrein)IBA 05/2014 - 08/2012
3	Kallikreins (Kallikrein)IBA 05/2014 - 08/2012
3	SaltsIBA 03/2013 - 06/2011
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 11/2020
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 09/2016
2	8-Hydroxy-2'-DeoxyguanosineIBA 01/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2003
2	ORALIT (ORS)IBA 10/2019 - 12/2011
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 01/2016
2	Peptides (Polypeptides)IBA 12/2018 - 09/2015
2	pro-brain natriuretic peptide (1-76)IBA 12/2018 - 03/2017
2	Vasodilator Agents (Vasodilators)IBA 12/2018 - 09/2015
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2018 - 01/2014
2	H-cadherin (T-cadherin)IBA 12/2017 - 12/2017
2	Hemoglobins (Hemoglobin)IBA 11/2017 - 09/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017 - 10/2011
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 06/2017 - 05/2015
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2017 - 05/2014
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2016 - 02/2015
2	Antidepressive Agents (Antidepressants)IBA 12/2016 - 12/2015
2	IsoprostanesIBA 02/2016 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015 - 12/2011
2	Therapeutic UsesIBA 02/2015 - 07/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 04/2011
2	Natriuretic PeptidesIBA 05/2011 - 06/2010
1	A 113IBA 11/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021

Therapy/Procedure

12	Therapeutics 04/2020 - 04/2011
10	Surgical Amputation (Amputations) 01/2022 - 01/2015
6	Glycemic Control 01/2021 - 11/2015
4	Kidney Transplantation 01/2019 - 07/2012
3	Bariatric Surgery 01/2022 - 01/2018
2	Orthotic Devices (Orthosis) 01/2020 - 01/2016